Literature DB >> 15034198

Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.

Min Li1, Hisayuki Funahashi, Majambu Mbikay, Seiji Shioda, Akira Arimura.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is found not only in the brain, but is also abundantly expressed in the testicular germ cells. However, the physiological role of testicular PACAP remains unknown. Autoradiographic studies showed a considerable number of PACAP-specific binding sites in the seminiferous tubules. Immunohistochemistry demonstrated PAC1-receptor (R)-like immunoreactivity (li) in the cytoplasm of round spermatids, aggregated in the acrosome and coexpressed with PACAP-li. Spermatid-enriched fractions were examined for the subcellular localization of PACAP binding sites and PAC1-R-li. The highest levels of PACAP binding sites and PAC1-R-li were found in the cytosolic, followed by the nuclear, and the lowest levels in the membrane fraction. The testicular cytosolic PAC1-R-like protein showed a specific competitive inhibition in the radio-receptor assay for PACAP38 and 27, with a Ki of 0.069 nM and 0.179 nM, respectively. The addition of PACAP to the cytosol of spermatids only slightly activated adenylate cyclase, while it markedly stimulated the expression and activation of ERK-type mitogen-activated protein kinase (MAPK). In the PAC1-R-like protein-depleted cytosol, a PAC1-R-specific agonist, maxadilan, did not activate MAPK, but PACAP and VIP still did. Because VPAC2-R, which binds both PACAP and VIP, is expressed in the testis, the findings suggest that cytosolic VPAC2-R-like proteins are also present and coupled to MAPK. The MAPK activation does not seem to require a heterotrimeric G-protein. Because PACAP and its receptors are coexpressed in the cytoplasm of spermatids, endogenous PACAP may directly interact with the cytosolic PAC1-R-like protein without the ligand being released into the extracellular space. This possibility is supported by the observation that cytosolic endogenous PACAP in spermatids was co-immunoprecipitated with the cytosolic PAC1-R. This mechanism may be called "intracrine," and its physiological significance is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034198     DOI: 10.1385/ENDO:23:1:59

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  66 in total

1.  Vasoactive intestinal peptide stimulates testosterone production by cultured fetal rat testicular cells.

Authors:  F El-Gehani; M Tena-Sempere; I Huhtaniemi
Journal:  Mol Cell Endocrinol       Date:  1998-05-25       Impact factor: 4.102

2.  Impaired fertility in mice deficient for the testicular germ-cell protease PC4.

Authors:  M Mbikay; H Tadros; N Ishida; C P Lerner; E De Lamirande; A Chen; M El-Alfy; Y Clermont; N G Seidah; M Chrétien; C Gagnon; E M Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

3.  Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene.

Authors:  S P Sreedharan; J X Huang; M C Cheung; E J Goetzl
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  The zona pellucida-induced acrosome reaction of human spermatozoa involves extracellular signal-regulated kinase activation.

Authors:  S S du Plessis; C Page; D R Franken
Journal:  Andrologia       Date:  2001-11       Impact factor: 2.775

5.  Evidence that pituitary adenylate cyclase-activating polypeptide is a potent regulator of fetal rat testicular steroidogenesis.

Authors:  F El-Gehani; M Tena-Sempere; I Huhtaniemi
Journal:  Biol Reprod       Date:  2000-11       Impact factor: 4.285

6.  Identification of specific binding sites for vasoactive intestinal peptide in rat testis Leydig cells and study of developmental changes.

Authors:  C Hueso; M J Carmena; J C Prieto
Journal:  Biochem Int       Date:  1989-11

7.  Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors.

Authors:  M Li; S Shioda; A Somogyvári-Vigh; H Onda; A Arimura
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

8.  PACAP acts through VIP type 2 receptors in the rat testis.

Authors:  K Krempels; T B Usdin; G Harta; E Mezey
Journal:  Neuropeptides       Date:  1995-12       Impact factor: 3.286

9.  Testicular expression of PC4 in the rat: molecular diversity of a novel germ cell-specific Kex2/subtilisin-like proprotein convertase.

Authors:  N G Seidah; R Day; J Hamelin; A Gaspar; M W Collard; M Chrétien
Journal:  Mol Endocrinol       Date:  1992-10

10.  Spermatogenic cells of the prepuberal mouse. Isolation and morphological characterization.

Authors:  A R Bellvé; J C Cavicchia; C F Millette; D A O'Brien; Y M Bhatnagar; M Dym
Journal:  J Cell Biol       Date:  1977-07       Impact factor: 10.539

View more
  6 in total

Review 1.  PACAP: A regulator of mammalian reproductive function.

Authors:  Stephen J Winters; Joseph P Moore
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

2.  Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility.

Authors:  R Brubel; P Kiss; A Vincze; A Varga; A Varnagy; J Bodis; L Mark; E Jambor; G Maasz; H Hashimoto; Zs Helyes; G Toth; A Tamas; M Koppan; D Reglodi
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

3.  Seasonal changes in the expression of PACAP, VPAC1, VPAC2, PAC1 and testicular activity in the testis of the muskrat (<em>Ondatra zibethicus</em>).

Authors:  Zeqi Tang; Xiaojie Yuan; Yuming Bai; Yiming Guo; Haolin Zhang; Yingying Han; Zhengrong Yuan; Qiang Weng
Journal:  Eur J Histochem       Date:  2022-05-02       Impact factor: 1.966

4.  Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells.

Authors:  Natalia Kasica; Piotr Podlasz; Maria Sundvik; Andrea Tamas; Dora Reglodi; Jerzy Kaleczyc
Journal:  Neurotox Res       Date:  2016-08-24       Impact factor: 3.911

Review 5.  PACAP38 and PAC1 receptor blockade: a new target for headache?

Authors:  Eloisa Rubio-Beltrán; Edvige Correnti; Marie Deen; Katharina Kamm; Tim Kelderman; Laura Papetti; Simone Vigneri; Antoinette MaassenVanDenBrink; Lars Edvinsson
Journal:  J Headache Pain       Date:  2018-08-07       Impact factor: 7.277

6.  Alzheimer's Disease Mouse as a Model of Testis Degeneration.

Authors:  Vince Szegeczki; Gabriella Horváth; Helga Perényi; Andrea Tamás; Zsolt Radák; Dóra Ábrahám; Róza Zákány; Dora Reglodi; Tamás Juhász
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.